TrialNature cancer2025

Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial.

Edith Borcoman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.